ESMO podcast on upper gastrointestinal cancers—highlights in esophagogastric cancers from ASCO 2025
In this episode of the ESMO Upper GI Cancer podcast, moderator Dr Jeroen Dekervel is joined by international experts Dr Elizabeth Smyth (Oxford, UK), Dr Sylvie Lorenzen (Munich, Germany), and Dr Thierry Alcindor (Boston, USA) to review and interpret the most practice-relevant upper gastrointestinal oncology trials presented at ASCO 2025. The discussion focuses on major developments in esophageal, gastroesophageal junction, and gastric cancers, with particular attention to immunotherapy integration and human epidermal growth factor receptor 2 (HER2)-directed strategies.
Authors
- Sylvie Lorenzen
- T. Alcindor
- Jeroen Dekervel (ORCID: https://orcid.org/0000-0001-7208-3480)
- Elizabeth Smyth
Institutions
- Churchill Hospital (GB)
- Dana-Farber Cancer Institute (US)
- Technical University of Munich (DE)
- KU Leuven (BE)
Publication Details
- Journal
- ESMO Gastrointestinal Oncology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1016/j.esmogo.2025.100233
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00